What microorganisms cause preseptal cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Microorganisms Causing Preseptal Cellulitis

The most common microorganisms causing preseptal cellulitis are Streptococcus species (particularly group A Streptococcus/S. pyogenes) and Staphylococcus aureus, with increasing prevalence of community-acquired MRSA in recent years. 1, 2

Common Causative Pathogens

Primary Pathogens

  • Streptococcus species - often group A (S. pyogenes), but also groups B, C, or G streptococci 1, 3
  • Staphylococcus aureus - including both methicillin-sensitive and methicillin-resistant strains 1, 2
  • Haemophilus influenzae B - historically common but has decreased significantly due to vaccination 4, 5
  • Streptococcus pneumoniae 4
  • Moraxella catarrhalis 4

Less Common Pathogens

  • Proteus species - rare but documented in case reports 6
  • Pseudomonas aeruginosa - particularly in immunocompromised patients 2

Pathogenesis and Risk Factors

  • Preseptal cellulitis typically results from:

    • Direct trauma to the eyelid 1
    • Extension from adjacent sinusitis (particularly ethmoid sinusitis) 1
    • Preexisting skin infections such as impetigo 1
    • Insect bites or other breaks in the skin barrier 1
  • Risk factors for more severe infections include:

    • Young age (more common in children) 5
    • Immunocompromised status 3
    • Diabetes 1
    • Recent trauma to the periorbital region 3

Clinical Considerations

Diagnostic Approach

  • Preseptal cellulitis is distinguished from orbital cellulitis by the absence of:

    • Proptosis
    • Limitation of extraocular movements
    • Pain with eye movements
    • Visual impairment 1, 4
  • Imaging (CT orbits with IV contrast) is the most useful tool to differentiate preseptal from orbital cellulitis and to detect complications 1

Treatment Implications

  • Empiric antibiotic therapy should target both streptococci and staphylococci 1

  • For mild cases, oral beta-lactams may be sufficient in areas where CA-MRSA is not prevalent 1

  • Suitable oral agents include:

    • Dicloxacillin
    • Cephalexin
    • Clindamycin
    • Erythromycin (with caution due to increasing resistance) 1
  • For more severe infections or when MRSA is suspected:

    • Consider parenteral therapy with agents effective against MRSA (vancomycin, linezolid, or daptomycin) 1
    • Step-down therapy may include trimethoprim-sulfamethoxazole or tetracyclines based on susceptibility results 1

Complications and Prognosis

  • Preseptal cellulitis typically has a good prognosis with appropriate antibiotic therapy 2

  • Potential complications include:

    • Progression to orbital cellulitis
    • Abscess formation
    • Lid necrosis
    • Cicatricial ectropion 2
    • In rare cases, severe complications like toxic shock syndrome (particularly with S. pyogenes) 3
  • Failure to respond to initial therapy should prompt consideration of:

    • Resistant organisms
    • Abscess formation requiring drainage
    • Misdiagnosis (orbital rather than preseptal involvement) 6, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pre-septal cellulitis--varied clinical presentations.

Indian journal of ophthalmology, 1996

Research

Preseptal cellulitis with Streptococcus pyogenes complicated by streptococcal toxic shock syndrome: A case report and review of literature.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023

Research

Paediatric orbital and periorbital infections.

Current opinion in ophthalmology, 2019

Research

Preseptal cellulitis secondary to Proteus species: a case report and review.

Journal of the American Optometric Association, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.